Efficacy of empagliflozin for weight and glycemic control of a patient with Prader-Willi syndrome, systemic lymphedema and extreme obesity: a case report

AbstractCase ReportA patient with Prader-Willi syndrome (PWS), extreme obesity and hyperglycemia had her body weight increased considerably for 6 months, even with exercise and diet programs. Treatment with metformin and empagliflozin (12.5 mg/day) induced a weight loss of 14 kg ( −10.3%) for 6 months and the reduction of glycated hemoglobin A1c.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research